Company profile

Cadrenal Therapeutics, Inc. Insider Trading

CVKD

Every SEC Form 4 insider trading filing for Cadrenal Therapeutics, Inc. (CVKD) since April 2023 — open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC. Why 2023?

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
CIK
0001937993
Filings
47
Insiders
10
Last filing
2026-06-29

Activity summary

No insider transactions in the last 30 days. The most recent was on June 29, 2026, when Pham Quang X sold 7,400 shares. 47 filings from 10 insiders are on record below.

Three year balance

Buy and sell value by quarter, Q3 23 to Q2 26. Cadrenal Therapeutics, Inc. insiders are net sellers across the period shown.

Q3 23Q4 23Q1 24Q2 24Q1 25Q3 25Q4 25Q2 26

Bars below the rule are sales, above are purchases. Largest quarter on the chart is $412K.

90 day insight

Over the last 90 days, Cadrenal Therapeutics, Inc. insiders filed 19 Form 4 transactions, none of which were open-market purchases or sales.

  • Most active insider: Pham Quang X with 19 transactions totaling $327K.
  • Largest single sale: $53K by Pham Quang X on Jun 9, 2026.
  • 100% of recent sales were pre-scheduled 10b5-1 trades — typically less informative than open-market activity.

Activity skews bullish — buys outpace sales.

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
Jun 29, 2026Pham Quang XCVKD
Sale10b5
7,400$3.03$22K
Jun 26, 2026Pham Quang XCVKD
Sale10b5
9,029$3.05$28K
Jun 25, 2026Pham Quang XCVKD
Sale10b5
2,127$3.00$6K
Jun 23, 2026Pham Quang XCVKD
Sale10b5
2,277$3.20$7K
Jun 22, 2026Pham Quang XCVKD
Sale10b5
9,167$3.55$33K

45 more transactions hidden

Free account · No credit card required

Building something? Get API access →

Query this yourself

The same rows, over the API.

curl "https://api.form4api.com/v1/transactions?ticker=CVKD" \
  -H "X-Api-Key: $KEY"
Get a key

Top insiders

By total value filed.

Pham Quang XChairman and CEO33 filings$701K
Szot Matthew KChief Financial Officer12 filings$397K

Institutional Ownership

Top 13F-HR holders of Cadrenal Therapeutics, Inc. as of 2026-06-30

— stable
Total reported AUM
$6,997
QoQ change
Reporting period
2026-06-30
#1
Grove Bank & Trust
CIK 0001662212
$3,340
1K shares
#2
Clearstead Advisors, LLC
CIK 0000842775
$2,171
650 shares
#3
Quest 10 Wealth Builders, Inc.
CIK 0002035215
$1,269
380 shares

Data source: quarterly 13F-HR filings — institutional holders report positions within 45 days of quarter end. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →